A Rare Loss for U.S. Pharma Lobby Will Cost the Industry Billions

Photo of A Rare Loss for U.S. Pharma Lobby Will Cost the Industry Billions
Facebook
VKontakte
share_fav

An employee uses a machine that sorts pills prior to packaging at a Sanofi-Aventis SA factory in Compiegne, France, on Friday, Oct. 8, 2010. Sanofi-Aventis SA's three-month effort to acquire Genzyme Corp. took a more contentious turn as the companies' chief executive officers offered conflicting accounts of their face-to-face meeting last month. Photographer: Antoine Antoniol

view Bloomberg Politics
#claire mccaskill
#consumer staples
#capitol hill
#family
#drugs
#science
#consumer discretionary
#congress
#commodity futures
#futures markets
#andrea harris